Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
SC=Subcutaneous
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects ≥18 years of age
Diagnosis of Rheumatoid Arthritis confirmed by participant's physician
Disease activity under control
You may not be if
Change in disease-modifying antirheumatic drug (DMARD) therapy within 3 months of enrollment
Exposure to investigational drug within 4 weeks or 5 half lives whichever is longer
Current or prior use of Rituximab ≤6 months
Current or prior use of the following within 4 weeks or 5 half lives whichever is longer: biologic DMARDS, Tofacitinib, Cyclophosphamide, Mycophenolate Mofetil \& d-Penicillamine
Clareo Health | Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe
